Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

Endocrinologist Jennifer Green discusses how GLP-1 drugs, like Ozempic, evolved from diabetes tools to potential treatments for addiction and heart disease, in this final installment of the obesity series. The discussion also touches on critical questions about long-term use, access, and emerging innovations. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-5-connecting-dots-broader-applications-glp-1s-and-where-were-headed-next

Avsnitt(45)

Populärt inom Vetenskap

p3-dystopia
svd-nyhetsartiklar
dumma-manniskor
kapitalet-en-podd-om-ekonomi
allt-du-velat-veta
doden-hjarnan-kemisten
rss-ufo-bortom-rimligt-tvivel-2
rss-vetenskapsradion-2
rss-vetenskapsradion
det-morka-psyket
bildningspodden
sexet
medicinvetarna
paranormalt-med-caroline-giertz
rss-spraket
har-vi-akt-till-mars-an
rss-experimentet
dumforklarat
barnpsykologerna
rss-tidsmaskinen